Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
NCT00757263 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2013-08-26
Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This study is looking at genetic susceptibility for cancer and interactions between genes and the environment in patients with ovarian cancer.
Conditions
Interventions
- GENETIC
-
polymorphism analysis
- OTHER
-
laboratory biomarker analysis
- OTHER
-
questionnaire administration
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Paul Pharoah, MD · Cancer Research UK
Eligibility
- Min Age
- 18 Years
- Max Age
- 74 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-02-29
Countries
- United Kingdom
Study Locations
More Related Trials
-
Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer
NCT02406235 ·Status: COMPLETED
-
Study of Circulating Tumoral DNA in Ovarian Cancer
NCT01350908 ·Status: COMPLETED ·Phase: NA
-
Feasibility of Multi-gene Panel Testing at the Time of Diagnosis for Patients With Ovarian Cancer
NCT03656809 ·Status: COMPLETED
-
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
NCT00043472 ·Status: COMPLETED
-
Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer
NCT00039559 ·Status: UNKNOWN ·Phase: NA
-
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
NCT01074398 ·Status: UNKNOWN
-
Search for Predictors of Therapeutic Response in Ovarian Carcinoma
NCT01391351 ·Status: COMPLETED ·Phase: NA
-
Prevalence of BRCA1 and BRCA2 Mutations in Ovarian Cancer Patients in the Gulf Region
NCT03082976 ·Status: COMPLETED
-
Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian Cancer
NCT06019923 ·Status: RECRUITING
-
Genomic BRCA and Extensive ovArian Cancer Testing
NCT04027868 ·Status: COMPLETED
-
Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
NCT01139957 ·Status: COMPLETED
-
Development of a Patient Reported Outcome Measure for Advanced Ovarian Cancer Patients Receiving Surgical and Chemotherapy Treatment
NCT05274867 ·Status: UNKNOWN
-
Ovarian Screening Study
NCT00267072 ·Status: COMPLETED
-
Cancer Loyalty Card Study
NCT03994653 ·Status: COMPLETED
-
Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
NCT00897806 ·Status: TERMINATED
-
Circulating Tumor DNA as an Early Marker of Recurrence and Treatment Efficacy in Ovarian Carcinoma
NCT03302884 ·Status: UNKNOWN ·Phase: NA
-
Patient Reported Symptoms in Ovarian Cancer (PRECISION)
NCT01422265 ·Status: COMPLETED
-
Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective Study
NCT06085456 ·Status: RECRUITING
-
China Ovarian Cancer BRCA Testing Study
NCT03203993 ·Status: TERMINATED
-
Study Looking at Biomarkers in Ovarian Cancer
NCT03419689 ·Status: RECRUITING ·Phase: NA
-
Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer
NCT03691012 ·Status: UNKNOWN
-
Appraising Medical Trial Experiences of Ovarian Cancer Patients
NCT05801796 ·Status: NOT_YET_RECRUITING
-
Evaluation of the Predictive Value of Blood Levels of Angiopoietin 1 and Endothelial Internal Tunica Cell Kinase 2 in Patients With Ovarian Cancer Treated With Chemotherapy Associated to Bevacizumab
NCT04770376 ·Status: UNKNOWN
-
Genetic Mutation in Epithelial Ovarian Cancer
NCT04191252 ·Status: UNKNOWN
-
Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2
NCT03296826 ·Status: RECRUITING